Ad Scientiam Company
Ad Scientiam develop reliable solutions to measure disease evolution to accelerate treatment decisions to fight the disabilities.
Total Funding:
$1.6M
Headquarters:
Paris, Ile-de-France, France
Employee Number:
11-50
Estimated Revenue:
Less than $1M
Last Funding Type:
Seed
Technology:
Others
Investor Type:
For Profit
Investors Number:
5
Founded Date:
05.09.2013
Industry:
Deep Diagnostics